Chong Kun Dang Pharmaceutical (185750) — Net Asset Momentum
Chong Kun Dang Pharmaceutical (185750) recorded a net asset momentum of 9.9% as of December 2024, with net assets of ₩896.38 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 185750 days of operational coverage to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Chong Kun Dang Pharmaceutical Net Asset Momentum (2016–2024)
This chart tracks Chong Kun Dang Pharmaceutical's year-over-year net asset growth across 9 annual reporting periods from 2016 to 2024. The most recent momentum reading is +9.9%, with net assets of ₩896.38 Billion KRW as of December 2024. Read 185750 current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Chong Kun Dang Pharmaceutical (2016–2024)
The table below shows the complete annual net asset history for Chong Kun Dang Pharmaceutical from 2016 to 2024, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 185750 market cap.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ₩896.38 Billion | ₩1.46 Trillion | ₩562.39 Billion | ▲ +9.9% |
| 2023 | ₩815.64 Billion | ₩1.40 Trillion | ₩586.79 Billion | ▲ +31.3% |
| 2022 | ₩621.29 Billion | ₩1.12 Trillion | ₩503.59 Billion | ▲ +9.8% |
| 2021 | ₩565.81 Billion | ₩1.05 Trillion | ₩480.89 Billion | ▲ +2.6% |
| 2020 | ₩551.59 Billion | ₩946.33 Billion | ₩394.74 Billion | ▲ +16.1% |
| 2019 | ₩474.95 Billion | ₩801.35 Billion | ₩326.40 Billion | ▲ +10.2% |
| 2018 | ₩430.90 Billion | ₩711.49 Billion | ₩280.60 Billion | ▲ +6.8% |
| 2017 | ₩403.29 Billion | ₩677.21 Billion | ₩273.91 Billion | ▲ +13.8% |
| 2016 | ₩354.25 Billion | ₩641.70 Billion | ₩287.45 Billion | — |